Apparatus and method for transdermal delivery of bupropion
AssigneePierce Management, LLC
InventorsKamal K. Midha, Hans E. Junginer, Mark Hirsh
Life of this patent
Estimating the term…
Abstract
The invention includes an apparatus and method for transdermal delivery of bupropion base. In the method of this invention, patient is administered parenterally a bupropion base in an amount effective to alleviate withdrawal symptoms and to prevent or reduce craving of nicotine in said patient. Alternatively, an effective amount of bupropion base is delivered to alleviate depression in a patient. A transdermal delivery system includes a bupropion base. The bupropion base can be mixed with an acceptable pharmaceutical carrier.
Claims17
A transdermal delivery system consisting essentially of a bupropion base in a therapeutically acceptable amount.
A method for treating withdrawal symptoms and preventing or reducing craving for nicotine in a patient, comprising:
- administering transdermally to a patient a composition consisting essentially of a bupropion base in an
- amount effective to alleviate withdrawal symptoms and to prevent
- or reduce craving of nicotine in said patient.
A method for alleviating depression in a patient, comprising:
- administering transdermally to a patient a, a composition consisting essentially of a bupropion base in an
- amount effective to alleviate depression in a patient.
Dependencies are inferred from the claim text.